Concepedia

Publication | Open Access

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

DOIFull Paper Access

173

Citations

18

References

2020

Year

Henny H. Billett, Morayma Reyes‐Gil, James Szymanski, Kenji Ikemura, Lindsay Stahl, Yungtai Lo, Shafia Rahman, Jesus D. Gonzalez‐Lugo, Margarita Kushnir, Mohammad Barouqa,
Thrombosis and Haemostasis

Abstract

We conclude that COVID-19+ patients with moderate or severe illness benefit from anticoagulation and that apixaban has similar efficacy to enoxaparin in decreasing mortality in this disease.

References

YearCitations

Page 1